Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 891-900 of 969 for hematology

Edit search filters
  1. A Study of Patients with Polycythemia Vera In US Clinical Practices

    Scottsdale/Phoenix, AZ

  2. A Study to Evaluate the Skin Microbiome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

    Jacksonville, FL

  3. Detection of Circulating tumor cells (CTC) from Patients with Hepatocellular Carcinoma (HCC)

    Rochester, MN

  4. Assessment of the Mechanical Properties of Lung Parenchyma using Magnetic Resonance Elastography in Lung Cancer

    Rochester, MN

  5. Global Cardio Oncology Registry

    Rochester, MN

  6. A Study of Characteristics and Post-surgical Outcomes of Pediatric Patients Diagnosed with Lipoblastoma

    Rochester, MN

  7. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders

    Jacksonville, FL

  8. A Comparison Study to Cross-validate the Linear Analogue Self-Assessment (LASA), Patient-Reported Outcomes Measurement Information System (PROMIS), and Patient-reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Assessing Cancer Patient Well-being

    Rochester, MN

  9. A Databank Study of Molecular Circulatory Biomarkers in Non-localized Renal and Testicular Cancer Patients

    Rochester, MN, Jacksonville, FL

  10. The Impact of Clinical Trials in Patients with Multiple Myeloma and Lymphoma

    Rochester, MN

.

Mayo Clinic Footer